(Q80457857)
Statements
Cost-effectiveness model for neovascular age-related macular degeneration: comparing early and late treatment with pegaptanib sodium based on visual acuity (English)
Jonathan C Javitt
Gergana P Zlateva
Stephanie R Earnshaw
Andreas M Pleil
Christopher N Graham
Anita J Brogan
Sonali N Shah
Anthony P Adamis
17 December 2007